Play 23 different addictive eWoss Games. It's FREE! Win money!
eWoss Sports
Home|News|Sports|Games
   
Home|NFL|MLB|NBA|NHL|College FB|College BK|Auto Racing
December 2, 2008 - 9:25 PM
NBA
NBA Home
Scores & Schedules
Standings
League Leaders
Transactions
Injuries
Teams
Players
eWoss Sports
eWoss Sports Home
NFL
NBA
NCAA Football
College Hoops
Womens College Hoops
NHL
MLB
Auto Racing
eWoss News
Breaking News Headlines
Top News Stories
U.S. National News
World News
Sports News
Business News
Entertainment News
Tech Industry News
Political News
Science News
Health News
Weird News
Wally Szczerbiak
The Boston Globe is reporting that Szczerbiak is ready to start a full-court work. The Celtic forward underwent knee surgery on April 11 after being bothered by the knee since joining the team in January. He did not play in the final seven games of the season after averaging 19 points this year.
(Updated 6/2/2006)

Game Logs
  REBOUNDS
  MIN PTS FG PCT FT PCT 3P PCT AST STL BLK TOT OFF DEF
Totals 1558 805 292-590 .495 163-182 .896 58-143 .406 112 21 15 190 36 154
Averages 39.0 20.1 7.3-14.8   4.1-4.6   1.5-3.6   2.8 0.5 0.4 4.8 0.9 3.9
Date OPP Result MIN PTS FG PCT FT PCT 3P PCT AST STL BLK TOT OFF DEF
11/2 POR W 90-86 34 16 7-15 .467 2-2 1.000 0-4 .000 0 0 0 6 3 3
11/4 @SEA L 102-107 30 16 7-16 .438 2-2 1.000 0-5 .000 4 1 0 5 2 3
11/5 @LAC L 99-100 36 4 1-6 .167 2-2 1.000 0-0 - 3 0 0 1 0 1
11/7 LAC W 93-78 35 15 5-16 .313 4-4 1.000 1-4 .250 3 0 0 4 0 4
11/9 LAL W 88-74 39 13 4-12 .333 5-5 1.000 0-1 .000 2 0 1 1 0 1
11/13 @DEN L 91-102 27 20 7-13 .538 2-2 1.000 4-5 .800 5 1 0 1 0 1
11/15 HOU L 89-94 32 12 5-14 .357 2-3 .667 0-5 .000 4 1 0 5 0 5
11/17 WAS W 109-98 35 17 7-16 .438 2-2 1.000 1-2 .500 5 0 0 7 2 5
11/19 CHA W 102-89 23 15 5-12 .417 5-6 .833 0-0 - 1 0 0 3 2 1
11/23 @NOK L 80-84 38 8 4-10 .400 0-1 .000 0-1 .000 0 1 0 7 1 6
11/25 MIL W 99-91 40 30 10-16 .625 9-10 .900 1-2 .500 6 1 2 6 0 6
11/26 @CLE W 89-85 31 16 5-7 .714 4-6 .667 2-4 .500 2 1 0 1 1 0
11/29 LAC L 84-93 32 10 3-9 .333 3-4 .750 1-2 .500 2 3 0 3 1 2
12/2 @LAL W 113-108 44 34 12-16 .750 6-6 1.000 4-5 .800 5 1 0 2 1 1
12/4 @SAC W 85-77 36 18 9-12 .750 0-0 - 0-2 .000 0 0 0 9 1 8
12/5 @UTA W 91-77 36 26 8-16 .500 7-8 .875 3-5 .600 0 0 0 4 1 3
12/7 @POR W 84-74 38 19 5-10 .500 8-11 .727 1-2 .500 2 1 0 4 2 2
12/10 LAL W 95-82 41 25 10-15 .667 3-5 .600 2-2 1.000 2 2 0 7 2 5
12/12 @PHI L 89-90 50 23 8-14 .571 3-3 1.000 4-9 .444 4 0 1 5 0 5
12/13 SAC L 91-93 45 25 9-20 .450 5-5 1.000 2-4 .500 4 0 0 8 4 4
12/15 SA L 88-90 46 23 8-16 .500 7-7 1.000 0-2 .000 3 0 0 6 0 6
12/18 @DAL L 95-102 41 28 11-24 .458 4-4 1.000 2-6 .333 1 0 1 5 0 5
12/21 NOK W 88-69 36 21 8-15 .533 3-3 1.000 2-4 .500 2 2 1 4 0 4
12/23 POR L 83-91 42 26 8-16 .500 7-7 1.000 3-6 .500 3 0 0 4 1 3
12/26 PHO L 89-103 48 27 12-21 .571 0-0 - 3-5 .600 3 1 1 5 1 4
12/28 SEA W 108-95 42 30 12-18 .667 3-3 1.000 3-5 .600 5 0 1 2 1 1
12/30 @ORL L 87-107 43 24 9-18 .500 4-6 .667 2-6 .333 6 0 0 4 0 4
1/1 @MIA L 70-97 36 19 7-17 .412 2-4 .500 3-5 .600 1 0 1 2 1 1
1/4 DAL W 91-78 44 20 8-14 .571 4-4 1.000 0-2 .000 2 0 1 5 0 5
1/6 @SA L 77-83 45 15 6-12 .500 2-3 .667 1-2 .500 2 0 1 3 0 3
1/7 @DAL L 79-83 44 25 9-18 .500 4-4 1.000 3-7 .429 1 0 0 10 2 8
1/10 @MIL L 92-95 32 20 7-13 .538 4-4 1.000 2-4 .500 2 0 1 5 1 4
1/11 CHI W 99-93 41 25 6-12 .500 11-12 .917 2-2 1.000 5 0 0 9 3 6
1/13 DEN W 103-89 42 28 11-20 .550 3-3 1.000 3-6 .500 4 0 0 5 0 5
1/16 @NY W 96-90 41 24 10-18 .556 3-3 1.000 1-3 .333 4 1 0 8 0 8
1/18 @BOS L 96-103 40 22 8-16 .500 6-6 1.000 0-5 .000 3 1 0 6 0 6
1/20 IND W 90-85 45 20 4-13 .308 12-12 1.000 0-2 .000 3 0 1 5 1 4
1/22 PHI L 84-86 44 18 7-16 .438 3-3 1.000 1-3 .333 2 1 0 6 0 6
1/24 DET L 83-107 40 13 3-8 .375 6-6 1.000 1-1 1.000 3 1 1 3 0 3
1/25 @MEM L 87-107 44 15 7-20 .350 1-1 1.000 0-3 .000 3 1 1 4 2 2
1/27 SAC W 84-74 24 10 4-7 .571 0-0 - 2-3 .667 2 1 0 3 1 2
1/29 @MIL L 79-83 41 20 8-15 .533 4-4 1.000 0-3 .000 3 0 0 3 1 2
1/30 @MIN L 85-110 38 22 6-15 .400 9-9 1.000 1-3 .333 3 1 0 3 1 2
2/1 PHO L 94-102 44 5 1-9 .111 2-2 1.000 1-4 .250 6 0 1 10 2 8
2/3 LAC L 81-98 42 18 8-17 .471 1-1 1.000 1-3 .333 10 0 1 8 4 4
2/4 @ORL L 91-100 45 13 6-13 .462 0-0 - 1-4 .250 0 1 0 3 2 1
2/6 @MIA L 98-114 40 16 5-15 .333 5-7 .714 1-4 .250 0 0 0 1 1 0
2/10 POR W 115-83 33 21 6-13 .462 7-8 .875 2-4 .500 5 1 0 2 0 2
2/12 ORL W 102-94 46 24 9-13 .692 4-4 1.000 2-3 .667 5 1 0 5 1 4
2/15 CLE L 109-113 46 17 7-19 .368 3-4 .750 0-3 .000 3 2 0 5 2 3
2/21 @UTA W 103-83 3 3 1-1 1.000 0-0 - 1-1 1.000 1 0 0 0 0 0
2/22 @PHO L 94-103 0 0 0-0 - 0-0 - 0-0 - 0 0 0 0 0 0
2/24 @POR W 102-96 39 25 8-19 .421 6-8 .750 3-5 .600 3 0 1 3 1 2
2/26 @LAL W 112-111 44 16 4-12 .333 5-5 1.000 3-5 .600 3 0 0 0 0 0
3/1 MIA L 96-103 39 12 5-10 .500 0-0 - 2-4 .500 4 1 0 6 2 4
3/3 IND W 99-98 35 13 5-13 .385 2-2 1.000 1-4 .250 1 0 0 3 1 2
3/5 @TOR L 105-111 37 23 7-13 .538 8-9 .889 1-3 .333 4 1 0 6 2 4
3/7 @WAS W 116-115 42 23 10-16 .625 2-4 .500 1-4 .250 4 1 0 5 3 2
3/8 PHI W 104-101 41 12 5-17 .294 0-0 - 2-5 .400 6 2 0 7 2 5
3/10 MIL L 86-92 37 18 6-15 .400 4-4 1.000 2-5 .400 4 0 0 5 1 4
3/12 DEN W 106-101 40 18 7-15 .467 2-2 1.000 2-7 .286 5 4 0 5 1 4
3/14 @MEM L 76-93 33 18 6-13 .462 2-2 1.000 4-6 .667 5 0 0 3 0 3
3/16 @MIA L 104-107 38 30 13-18 .722 2-2 1.000 2-3 .667 1 0 0 1 0 1
3/17 @ORL L 77-84 39 16 5-10 .500 6-6 1.000 0-1 .000 1 0 0 4 3 1
3/19 @IND W 103-88 35 16 6-10 .600 4-5 .800 0-0 - 3 0 0 4 0 4
3/20 LAL L 97-105 40 15 6-14 .429 1-1 1.000 2-6 .333 2 1 0 3 0 3
3/22 TOR W 110-96 32 19 7-9 .778 4-5 .800 1-2 .500 5 0 0 2 0 2
3/24 @CLE L 82-94 34 13 5-13 .385 2-2 1.000 1-4 .250 2 0 0 3 1 2
3/26 CHI L 97-101 36 23 7-19 .368 9-10 .900 0-2 .000 2 1